COMPANY

Cetya Therapeutics

HQ: Fort Collins, CO source · cetya-therapeutics.com ↗ · Mountain

Keywords: sickle cell disease

Location: Fort Collins, CO · source · Oct 14, 2026

Profile checked Oct 10, 2026

NIH awards 4

Annual award amounts. Total $1.3M.

Aug 20, 2020 NIH award 5R42HL136068-03 FY2020: $550,046 awarded for that fiscal year; activity R42 (STTR); PI PACE, BETTY SUE; recipient as written: CETYA THERAPEUTICS, INC., FORT COLLINS, CO. In Vivo Studies of a Novel HDAC Inhi source ↗
Apr 13, 2020 NIH award 3R42HL136068-02S1 FY2020: $24,589 awarded for that fiscal year; activity R42 (STTR); PI PACE, BETTY SUE; recipient as written: CETYA THERAPEUTICS, INC., FORT COLLINS, CO. In Vivo Studies of a Novel HDAC Inh source ↗
Sep 17, 2019 NIH award 2R42HL136068-02 FY2019: $499,220 awarded for that fiscal year; activity R42 (STTR); PI PACE, BETTY SUE; recipient as written: CETYA THERAPEUTICS, INC., FORT COLLINS, CO. In Vivo Studies of a Novel HDAC Inhi source ↗
Aug 30, 2017 NIH award 1R41HL136068-01 FY2017: $241,742 awarded for that fiscal year; activity R41 (STTR); PI WILLIAMS, ROBERT MICHAEL; recipient as written: CETYA THERAPEUTICS, INC., FORT COLLINS, CO. Novel HDAC Inhibitors for T source ↗